Ignite Creation Date:
2024-05-05 @ 11:52 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00155402
Status:
WITHDRAWN
Last Update Posted:
2008-05-29
First Post:
2005-09-08
Brief Title:
The Application of Fibrin Glue in Ocular Surface Diseases
Sponsor:
National Taiwan University Hospital
Organization:
National Taiwan University Hospital
Study Overview
Official Title:
Phase 1 Study of Applying Fibrin Glue in Patients With Corneal Ulcer or Patients Requiring Wound Closure by Suture
Status:
WITHDRAWN
Status Verified Date:
2005-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Short of supply of fibrin glue
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This clinical trial tries to use tissue fibrin glues Tisseel to treat various ocular surface diseases or surgeries which includes pterygium surgery corneal meltingperforation Gundersons flap conjunctival laceration and muscleclinicalfiltering surgery
Detailed Description:
This clinical trial tries to use tissue fibrin glues Tisseel to treat various ocular surface diseases or surgeries The inclusion criteria are
1 ocular surface disease which may need amniotic membrane transplantation corneal pro epithelization pterygium surgery etc
2 infectious or noninfectious corneal ulcer with perforation less than 3 mm
3 conjunctival transplantationsuture
4 corneal surgeries which can be treated by conventional suture technique or application with cyanoacrylic acid tissue glues
Informed consents will be obtained from the patients before applications After surgeries topical steroids and antibiotics will be used and therapeutic contact lens will be used The patients will be followed up for at least three months
1 ocular surface disease which may need amniotic membrane transplantation corneal pro epithelization pterygium surgery etc
2 infectious or noninfectious corneal ulcer with perforation less than 3 mm
3 conjunctival transplantationsuture
4 corneal surgeries which can be treated by conventional suture technique or application with cyanoacrylic acid tissue glues
Informed consents will be obtained from the patients before applications After surgeries topical steroids and antibiotics will be used and therapeutic contact lens will be used The patients will be followed up for at least three months
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None